RESEARCH NEWS 2020-07-10 Research News Tau tracers have invigorated Alzheimer’s research, but they initially proved disappointing for other tauopathies. That is now changing, with at least two tracers, PI-2620 and APN-1607, that appear to bind specifically to the 4R tau deposits
RESEARCH NEWS 2020-07-21 Research News How does mutant huntingtin protein cause striatal neurons to die? On July 17 in Neuron online, researchers led by Myriam Heiman at the Massachusetts Institute of Technology suggest that an early insult to mitochondria could kick off inflamma
RESEARCH NEWS 2020-07-24 Research News People with Alzheimer’s get lost in once-familiar places, often quite early in their disease. A study published July 13 in Neuron helps explain why. Researchers led by Kei Igarashi at the University of California, Irvine, reported that in AP
CONFERENCE COVERAGE 2020-07-31 Conference Coverage The list of rare and common genetic variants that sway a person’s risk of Alzheimer’s disease just got substantially longer, as researchers expanded both the breadth and depth of genomic studies aimed at uncovering the etiology of the
CONFERENCE COVERAGE 2020-08-01 Conference Coverage Numerous studies have now found that amyloid PET scans can alter a person’s diagnosis and disease management—but do they reduce overall medical costs? According to data from the final phase of the IDEAS study, presented at the virtual
CONFERENCE COVERAGE 2020-08-04 Conference Coverage At this year’s virtual Alzheimer’s Association International Conference, researchers presented an update to “Dementia prevention, intervention, and care,” the 2017 report commissioned by The Lancet. Published July 30, the new report id
CONFERENCE COVERAGE 2020-08-07 Conference Coverage Having established that poor cardiovascular health in midlife increases the risk of cognitive decline and dementia as a person ages, scientists are now pushing to see if the same relationship might hold true even earlier in life. Indee
RESEARCH NEWS 2020-08-08 Research News The fate of aducanumab now rests in the hands of regulators at the U.S. Food and Drug Administration (FDA). Biogen of Cambridge, Massachusetts, and Eisai Co. Ltd., Tokyo, announced on August 7 that the agency had accepted its Biologics Licen
CONFERENCE COVERAGE 2020-08-08 Conference Coverage Without the millions of thriving synapses that link them, neurons in the brain are useless. The crumbling of these tiny connective structures is widely viewed as the proximal step to cognitive impairment in Alzheimer’s disease. Yet, re